LexDanaLexDanabeta
Inventor

Esther Zwick-Wallasch

Inventor
Gauting, DE

Overview

4→
Patents
2009–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07KPeptides31%
A61KPreparations for medical, dental or toiletry purposes23%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
PatentTitleYear
8,933,202'AXL antibodies'20158,828,382'Heparin-binding epidermal growth factor-like growth factor binding proteins'20147,910,100'Antibodies directed to the mammalian EAG1 ion channel protein'20117,632,645'EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2011Patents assigned to MAX PLANCK GESELLSCHAFT (2)· patent assignee history
2009Based in München, DE· patent location history
2011–2015Based in Gauting, DE· patent location history
2014–2015Patents assigned to HETTMANN THORE (2)· patent assignee history
2014–2015Patents assigned to ROTHE MIKE (2)· patent assignee history
2014–2015Patents assigned to U3 PHARMA GMBH (2)· patent assignee history
2014–2015Patents assigned to ZWICK-WALLASCH ESTHER (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HETTMANN THORE22014–2015
MAX PLANCK GESELLSCHAFT22009–2011
ROTHE MIKE22014–2015
U3 PHARMA GMBH22014–2015
ZWICK-WALLASCH ESTHERself22014–2015
Locations
LocationPatentsSpan
Gauting, DE32011–2015
München, DE12009